HomeAbout GlaucomaYour TreatmentSafety InformationTalking to Your DoctorResource Center
Allergan At Your Service

Full-service assistance to help you manage your therapy

Allergan is proud to announce At Your Service, a comprehensive support program specifically designed for you.

Call 1-844-4-MyAllergan to get answers to your questions and discover additional available resources:

Product information
Prescription coverage answers
Savings assistance
Patient assistance program
Educational support
Medical Information Specialist

The call center is available Monday through Friday, 8:00 am to 5:00 pm, excluding holidays, in all continental US time zones.

Return to Resource Center

Indication: COMBIGAN® (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% is approved for reducing elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP. COMBIGAN® lowers IOP slightly less than taking both brimonidine tartrate three times a day and timolol maleate two times a day.

IMPORTANT SAFETY INFORMATION
Contraindications: COMBIGAN® ophthalmic solution should not be used by patients who have or ever had a reactive airway disease including bronchial asthma, chronic bronchitis, emphysema, slow heartbeat, impaired conduction of the heart, heart failure, or impaired pumping of the heart. COMBIGAN® should not be used in patients aged 2 years and younger, or by patients with hypersensitivity to any ingredient in this product.

See more below.